CVS HEALTH P Price on October 2, 2024
| 126650CD0 | 95.39 1.98 2.12% |
If you're considering investing in 126650CD0 Bond, it is important to understand the factors that can impact its price. As of today, the current price of 126650CD0 stands at 95.39, as last reported on the 11th of December 2024, with the highest price reaching 95.39 and the lowest price hitting 95.39 during the day. At this point, 126650CD0 is very steady. CVS HEALTH P secures Sharpe Ratio (or Efficiency) of 0.0157, which signifies that the bond had a 0.0157% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for CVS HEALTH P, which you can use to evaluate the volatility of the entity. Please confirm 126650CD0's Mean Deviation of 1.11, risk adjusted performance of 0.0151, and Downside Deviation of 2.82 to double-check if the risk estimate we provide is consistent with the expected return of 0.0159%.
126650CD0 Bond price history is provided at the adjusted basis, taking into account all of the recent filings.
126650CD0 |
Sharpe Ratio = 0.0157
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 126650CD0 |
Estimated Market Risk
| 1.01 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average 126650CD0 is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 126650CD0 by adding it to a well-diversified portfolio.
Related Headline
Recursion Pharmaceuticals Headline on 2nd of October 2024
Recursion Announces FDA Clearance of Investigational New Dru... by finance.yahoo.com
First program to combine Recursions end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 monthsPlan to initiate dosing of Phase 12 in Q4 2024 to evaluate REC-1245 in a biomarker enriched patient population, including patients with solid tumors and lymphoma SALT LAKE CITY, Oct. 02, 2024 -- Recursion , a leading clinical stage TechBio company decoding biology to industrialize drug discovery,
126650CD0 Valuation on October 2, 2024
It is possible to determine the worth of 126650CD0 on a given historical date. On October 2, 2024 126650CD0 was worth 96.04 at the beginning of the trading date compared to the closed value of 96.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of 126650CD0 bond. Still, in general, we apply an absolute valuation method to find 126650CD0's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of 126650CD0 where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against 126650CD0's related companies.
| Open | High | Low | Close | Volume | |
| 98.31 | 98.31 | 98.31 | 98.31 | 1.00 | |
10/02/2024 | 96.04 | 96.04 | 96.04 | 96.04 | 1.00 |
| 95.43 | 95.43 | 95.43 | 95.43 | 1.00 |
| Backtest 126650CD0 | | | 126650CD0 History | | | 126650CD0 Valuation | Previous | Next |
126650CD0 Trading Date Momentum on October 2, 2024
| On October 03 2024 CVS HEALTH P was traded for 95.43 at the closing time. The highest price during the trading period was 95.43 and the lowest recorded bid was listed for 95.43 . There was no trading activity during the period 1.0. Lack of trading volume on October 3, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 0.64% . The overall trading delta to the current price is 1.53% . |
About 126650CD0 Bond history
126650CD0 investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 126650CD0 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CVS HEALTH P will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing 126650CD0 stock prices may prove useful in developing a viable investing in 126650CD0
126650CD0 Bond Technical Analysis
126650CD0 technical bond analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, bond market cycles, or different charting patterns.
Price Boundaries
126650CD0 Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
CVS HEALTH P cannot be verified against its exchange. Please verify the symbol is currently traded on Bond Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
126650CD0 December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how 126650CD0 bond reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 126650CD0 shares will generate the highest return on investment. By undertsting and applying 126650CD0 bond market strength indicators, traders can identify CVS HEALTH P entry and exit signals to maximize returns
126650CD0 Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for 126650CD0's price direction in advance. Along with the technical and fundamental analysis of 126650CD0 Bond historical price patterns, it is also worthwhile for investors to track various predictive indicators of 126650CD0 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0151 | |||
| Jensen Alpha | 0.002 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.1279 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in 126650CD0 Bond
126650CD0 financial ratios help investors to determine whether 126650CD0 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 126650CD0 with respect to the benefits of owning 126650CD0 security.